key: cord-0943963-ff3st0pt
authors: de Macedo, V.; Santos, G. S.; Silva, R. N.; Couto, C.N.M.; Bastos, C.; Viecelli, E.; Mateus, M. N.; Graf, M. E.; Gonçalves, R. B.; Silva, M. A.; Bernardini, P.D.B.; Grando, R.S.P.; Boaventura, V. P.; Pereira, H.S.R.; Levin, A.S.S.
title: Healthcare-associated infections: a threat to the survival of patients with COVID-19 in intensive care units
date: 2022-05-25
journal: J Hosp Infect
DOI: 10.1016/j.jhin.2022.05.013
sha: 54f70e16118d397f7111f3b7a1c2348481e11be0
doc_id: 943963
cord_uid: ff3st0pt

Background A wide variation in mortality among critically ill patients with COVID-19 has been related. This study evaluated whether healthcare-associated infections (HAI) are a risk factor for death of patients with severe COVID-19 in the intensive care unit (ICU). Methods This retrospective cohort study included patients with severe COVID-19 hospitalised in the ICU of 4 hospitals in the city Curitiba, Brazil. During hospitalization in the ICU, patients with COVID-19 who died were compared with those who were discharged. A second analysis compared patients who developed HAI with those who did not in the ICU. Multiple logistic regression models were used to control for confounders. Results 400 patients were included. HAI occurred in 123 patients (31%). The most frequent infection was of the lower respiratory tract (67%). Independent risk factors for death were: age (OR: 1.75; 95%CI: 1.43-2.15; p<0.0001), clinical severity score (OR: 2.21; 95%CI:1.70-2.87; p<0.0001), renal replacement therapy (OR: 12.8; 95%CI: 5.78-28.6; p<0.0001), and HAI (OR: 5.9; 95%CI: 3.31-10.5; p<0.0001); while days between the onset of symptoms and hospital admission were protective (OR: 0.93; 95%CI:0.88-0.98; p=0.017). The only independent factors associated with HAI were high C-reactive protein and low PaO2/FiO2 ratio. Conclusions No factors that could point to a high-risk group for acquiring a HAI were identified. However, age, dialysis and HAI increased the risk of death in ICU patients with severe COVID-19, of which, HAI is the only preventable risk factor.

The link between viral outbreaks and secondary bacterial infections is well established as observed during influenza and coronaviruses pandemics [1, 2] . However, healthcareassociated infections (HAI) have been described in patients with COVID-19 with a highly variable incidence from 6.1% to 50.5% across studies, mostly above 15% [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] .

A wide variation in mortality among critically ill patients with COVID-19 has been described, between 15% and 75.9% [3, 4, 8, [12] [13] [14] reaching 97% among patients on invasive mechanical ventilation [15] . This variability has been explained by a mixture of different cases and organizations, variation of ICU beds availability among different countries, and different lengths of follow-up [12] . Few studies have assessed risk factors for mortality in critical COVID-19. Independent risk factors include older age, male gender, low PaO2:FiO2 ratio at hospital admission, comorbidities and higher Sequential Organ Failure Assessment (SOFA) score [10, 12, 14] . Even more scarce are the studies that explore how HAI influences the mortality of critically ill patients [3, 4, 9, 13] . Studies merely present mortality data for patients with COVID-19 with HAI without assessing whether they are in fact a prognostic factor and without analyzing the predictive factors for HAI [5] [6] [7] 9, 11, 12, 14] .

The objective of this study was to evaluate the risk factors for death and HAI for patients with COVID-19 under critical care.

This retrospective cohort study included a cohort of adult patients (≥18 years-old) with severe COVID-19 hospitalized in the intensive care units (ICU) of 4 hospitals in Curitiba, capital of the state of Paraná, largest city in Southern Brazil: Santa Casa with 249 beds (48 ICU beds); Trabalhador Hospital with 222 beds (40 ICU beds); Rehabilitation Hospital, with 82 beds (62 ICU beds) and, Institute of Medicine with 100 beds (60 ICU beds). The characteristics of the patients in each hospital are shown in Supplementary   Table S1 .

Patients with COVID-19 and with severe disease defined as patients with oxygen saturation (SpO2) ≤94% on room air, or requiring supplemental oxygen, or requiring mechanical ventilation, or requiring extracorporeal membrane oxygenation [16] admitted J o u r n a l P r e -p r o o f to an ICU from 1 March through 31 December, 2020 were consecutively included in the study. Inclusion was continued until there were 100 patients from each hospital.

COVID-19 was defined as an infection confirmed with a positive real-time reverse transcriptase polymerase chain reaction (RT-PCR) for SARS-CoV-2 from a nasopharyngeal swab. We excluded patients with non-severe disease and those with COVID-19 defined by serology or antigen test for SARS-COV-2.

Data were extracted from electronic medical records using a data collection form such as: demographic characteristics; clinical information (signs, symptoms, comorbidities); treatment and use of invasive devices at ICU (orotracheal tube, central venous catheter and indwelling urinary catheter); laboratory tests at ICU admission and at the moment of diagnosis of a HAI (C-reactive protein, total leukocyte count, number of lymphocytes, creatinine, glucose, D-dimer, troponin, and PaO2:FiO2 ratio) and radiologic alterations based on the medical report of the chest radiography or computed tomography (CT). Duration of the disease from the onset of symptoms, length of stay in the hospital and in the ICU were also documented.

WHO Clinical Progression Scale [17] was used to measure the illness severity of each patient on admission to the ICU: 0 (not infected); 1-3 (ambulatory mild disease); 4-5 (hospitalised with moderate disease); 6-9 (hospitalised: severe disease) and 10 (dead).

HAI were defined according to Brazilian national surveillance criteria [18] that are based on Centers for Disease Control and Prevention criteria [19] (Supplementary Table   S2 ). We only considered the first infection for each patient. Although the study was retrospective, diagnoses of HAI were obtained from the data produced by a designated surveillance team in each hospital. Thus, diagnoses of HAI were produced in real time using standardized criteria. Sample size calculation was performed using OpenEpi program,version 3.01, [20] with the following parameters: a confidence interval of 95%, a statistical power of 80%, a ratio of exposed and unexposed in the sample equal to 1.0, proportion of positive unexposed 5%, and an odds ratio of 3. The sample size was calculated to be 400. The description of continuous variables used means and categorical variables were described by frequency.

Two outcomes in the ICU were studied (dependent variables): death and HAI that were followed until discharge from the ICU. Therefore, during hospitalization in the ICU, patients with COVID-19 who died were compared with those who were discharged. A second analysis compared patients in the ICU who developed HAI with those who did not.

The possible association of demographic and clinical variables with each dependent variable were initially tested in a bivariate analysis calculating odds ratios and 95% confidence intervals for each variable. Variables potentially associated with the development of each dependent variable in bivariable analysis (P < 0.15) were included in a multivariable logistic regression model in order to determine the adjusted odds ratios. The variables age, C-reactive protein (CRP) and PaO2/FiO2 ratio were transformed from continuous variables to categorical variables. For age, 7 categories were used according to CDC criteria [21] which assessed the mortality risk for patients with COVID-19: 18-29 years; 30-39; 40-49; 50-64; 65-74; 75-84; and ≥ 85 years. For CRP, the cutoff point was 108 mg/L, based on the study [22] which observed an increase in mortality among patients with values above this cut-off. For PaO2/FiO2 four categories of severity classification of severe acute respiratory syndrome were used [23] : > 300mmHg; 200-299 mmHg; 100-199 mmHg, and <100 mmHg.

Statistical analyses were performed using EPI Info 7 Software (version 7.2.4, Centers for Disease Control and Prevention, Atlanta, EUA). P-values <0.05 were considered to be statistically significant.

Four hundred patients with severe COVID-19 hospitalized in ICUs were included, 100 patients from each hospital. Characteristics and outcomes of patients are shown in J o u r n a l P r e -p r o o f Tables I and II . Factors associated with increased risk of death in the bivariate analysis were: older age; hypertension; coronary heart disease; the presence of cough, fever, fatigue, and headache at hospital admission; low leukocyte count, high C-reactive protein, low PaO2/FiO2 ratio, high troponin, high d-dimer on ICU admission; renal replacement therapy; and HAI. In the multivariate analysis, the variables that significantly increased the risk of death were: age, HAI, WHO Clinical Progression Scale, and renal replacement therapy, while the interval between the onset of symptoms and hospital admission was a protective factor. For each age category there was an increase in the risk of death by 75%. HAI increased the risk of dying 6 fold (OR: 5.9; CI: 3.31-10.5; p p<0.0001). The clinical severity according to the WHO scale increased the risk of dying 2 fold per point, and undergoing renal replacement therapy increased the risk 13-fold (Table I) .

Among 400 patients studied, 123 had HAI (Table II) More than a fifth of HAI were caused by MDR bacteria: CR-Acinetobacter baumannii;

CR-Enterobacterales; MRSA; CR-Pseudomonas; and VRE (Table III) .

In the bivariate analysis for factors associated with HAI, there was a statistically significant difference in the mean number of days of use of invasive devices. WHO Clinical Progression Scale, CRP and PaO2/FiO2 values at ICU admission was higher in the HAI group. In multivariable analysis, CRP above 108 mg/L increased 2-fold the risk of HAI (OR: 2.02; 95% CI: 1.17-3.47; p: 0.010). The PaO2/FiO2 ratio increased the chance of having HAI by 29% for each category (OR: 1.29; 95% CI: 1.01-1.66; p: 0.04).

In this retrospective cohort study of 400 patients with COVID-19 admitted to the ICU of 4 hospitals, we found that the independent factors associated with death were age, clinical severity score on admission to the ICU, dialysis, and HAI, while the interval between the onset of symptoms and hospitalization was inversely associated with the risk of dying. No factors that could point to a high-risk group for acquiring a HAI were identified.

As HAI is the only modifiable factor associated with death, we have decided to try to identify independent factors associated with HAI. Could it be possible to identify which patients were at a higher risk, thus to implement preventive measures directed to this population? We observed that only CRP and the PaO2/FiO2 ratio proved to be factors associated with HAI. Unfortunately, these alterations may represent the consequence and not the cause or risk factors for HAI. Because of their severity, they will require mechanical ventilation, invasive devices for prolonged periods, and are therefore more susceptible to healthcare-associated infections, especially of the lower respiratory tract [6] .

However, in our study, the length of stay in the ICU, the use of invasive devices, as well as age, comorbidities, and symptoms, were not able to predict which patients would develop a HAI. It does not seem possible to identify which patients are at an increased risk for HAI, which in turn increases the risk of death by 6 times. This risk was close to that found by Shafran et al. [13] , in which one infection increased the risk of death by 2.48 times; and having more than one infection increased the risk of death by 7.64 times in patients with COVID-19.

It is important however to stress that a large proportion of HAI caused by MDR bacteria such as CR-Acinetobacter spp. are preventable by implementing effective infection prevention control measures. In our study, 123 patients had 139 HAI because, of which 29.1% (37/127 isolates) were MDR bacteria. One of the possible explanations could be the use extensive of antimicrobials, especially at the beginning of the pandemic, when the clinical course of COVID-19 was not yet clear and there was a shortage of diagnostic tools [24] . In addition, in many countries, such as Brazil, the large strain put on the healthcare system posed by COVID-19, led to high demand for healthcare workers and shortages of specialized and experienced personnel in hospitals with J o u r n a l P r e -p r o o f inadequate infrastructure, contributing to cross-transmission of pathogens between patients and MDR bacteria outbreaks.

Dialysis was associated with death in our study. The same mechanisms underlying the development of severe acute respiratory syndrome in COVID-19 appear to lead to acute kidney injury, including viral septicaemia, an enhanced inflammatory response and endothelial damage [25] .

The strengths of our study are the large number of patients, and its multicenter design.

However, our study is limited by its retrospective design that reduces control over multiple confounders and data collection. Also, in our study we included only the first episode of infection which may lead to an underestimation of the true burden of HAI infections. Furthermore, although this is a multicenter study, only hospitals in Curitiba (Southern Brazil) were included, which may not reflect the reality of other geographical regions of Brazil. Finally, these hospitals could have had some differences in patterns of care and resources, that could be associated with the two outcomes of interest.

This study identified that age, dialysis, and HAI increased the risk of death among patients with severe COVID-19 in intensive care units. PaO2/FiO2 and CRP were associated with HAI, but they seem to be a consequence of the infection. We found no important factors that could define a population at increased risk for HAI. As a consequence of this, infection prevention and control measures should be prioritized in order to reduce the impact of COVID-19 in critically ill patients, especially mortality. 

Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness

Bacterial coinfections in coronavirus disease 2019

Nosocomial infections associated to COVID-19 in the intensive care unit: clinical characteristics and outcome

Nosocomial infection among patients with COVID-19: a retrospective data analysis of 918 cases from a single center in Wuhan

Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in

China: a retrospective analysis

Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study

Bacterial pneumonia in COVID-19 critically ill patients: a case series

Clinical features of patients infected with COVID-2019 novel coronavirus in Wuhan, China

Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?

Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy

Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients

Factors associated with death in critically ill patients with coronavirus disease 2019 in the US

Clinical course and outcomes of 344 intensive care patients with COVID-19

WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection. A minimal common outcome measure set for COVID-19 clinical research

Critérios diagnósticos de infecções relacionadas à assistência à saúde/Agência Nacional de Vigilância Sanitária

Surveillance Definitions for Specific Types of Infections

OpenEpi: Open source epidemiologic statistics for public health website

Risk for COVID-19 infection, hospitalization, and death by age group

C-reactive protein and clinical outcomes in patients with COVID-19

Spanish initiative for epidemiology, stratification, and therapies for ARDS (SIESTA) network

A universal definition of ARDS: the PaO2/FiO2 ratio under a standard ventilatory setting--a prospective, multicenter validation study

Antimicrobial use, drug-resistant infections and COVID-19

The COVID-19 pandemic: consequences for nephrology